This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Lifshitz Law Firm Announces Investigation Of Exide Technologies, Star Scientific, Inc., And Sterling Bancorp

NEW YORK, April 9, 2013 /PRNewswire/ --

Exide Technologies

Lifshitz Law Firm announces that it is investigating potential claims against the board of directors of Exide Technologies (XIDE).  On March 22, 2013 the South Coast Air Quality Management District (AQMD) announced it had reviewed and approved a health risk assessment from Exide Technologies showing that the Vernon facility is causing a potential health impact to residents in a large geographical area that includes portions of Vernon, Maywood, Huntington Park, Commerce, Boyle Heights and unincorporated areas of east Los Angeles.  Under a California law commonly known as the Toxic Hot Spots program, facilities that emit toxic air pollutants must develop health risk assessments using scientific tools to estimate the risk of cancer as well as non-cancer health effects to residents.  If the risk is higher than 25 in 1 million, the facility must develop and implement a plan to reduce it below that threshold within three years.  The AQMD stated that Exide's health risk assessment shows a maximum cancer risk of 156 in 1 million, mostly due to arsenic emissions, to workers at a facility in Vernon next to Exide.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Star Scientific, Inc.  

Lifshitz Law Firm announces that that a class action suit was filed in the United States District Court for the Eastern District of Virginia on behalf of purchasers of Star Scientific, Inc.  ("Star Scientific") (STSI) between October 31, 2011 and March 18, 2013 ("Class Period").  The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose certain private placements and related party transactions since 2006 involving Star Scientific securities.  The firm is investigating legal claims against the officers and Board of Directors of Star Scientific during the Class Period.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Sterling Bancorp

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Sterling Bancorp (NYSE: STL) ("Sterling") to Provident New York Bancorp ("Provident") in a stock-for-stock transaction valued at $344 million, based on the closing price of Provident common stock on April 3, 2013.  Sterling shareholders will receive a fixed ratio of 1.2625 shares of Provident common stock for each share of Sterling common stock.  Upon closing, Provident shareholders will own approximately 53% of stock in the combined company; Sterling shareholders will own approximately 47%.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,086.63 -26.91 -0.16%
S&P 500 1,987.01 +3.48 0.18%
NASDAQ 4,473.6970 +17.6810 0.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs